Early evolutionary divergence between papillary and anaplastic thyroid cancers

被引:48
作者
Capdevila, J. [1 ]
Mayor, R. [1 ]
Mancuso, F. M. [1 ]
Iglesias, C. [2 ]
Caratu, G. [1 ]
Matos, I. [1 ]
Zafon, C. [1 ]
Hernando, J. [1 ]
Petit, A. [3 ]
Nuciforo, P. [1 ]
Cameselle-Teijeiro, J. M. [4 ]
Alvarez, C. [4 ]
Recio, J. A. [2 ]
Tabernero, J. [1 ,5 ,6 ]
Matias-Guiu, X. [3 ,5 ,7 ]
Vivancos, A. [1 ]
Seoane, J. [1 ,5 ,6 ,8 ]
机构
[1] Vall dHebron Univ Hosp, Vall dHebron Inst Oncol VHIO, Barcelona, Spain
[2] Vall dHebron Univ Hosp, Vall dHebron Inst Res VHIR, Barcelona, Spain
[3] Univ Barcelona, Hosp Univ Bellvitge, Dept Pathol, IDIBELL, Barcelona, Spain
[4] Univ Santiago de Compostela, Clin Univ Hosp, Santiago De Compostela, Spain
[5] CIBERONC, Barcelona, Spain
[6] Univ Autonoma Barcelona, Cerdanyola Del Valles, Spain
[7] Univ Lleida, Hosp Univ Arnau de Vilanova Lleida, IRBLleida, Dept Pathol, Lleida, Spain
[8] ICREA, Barcelona, Spain
关键词
anaplastic thyroid cancer; papillary thyroid cancer; genomic evolution; exome sequencing; INTRATUMOR HETEROGENEITY; DISCOVERY; CARCINOMA; FRAMEWORK; MUTATION; DNA;
D O I
10.1093/annonc/mdy123
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background Papillary thyroid cancer (PTC) is the most common thyroid carcinoma and exhibits an almost uniformly good prognosis, while anaplastic thyroid cancer (ATC) is less frequent and is one of the most aggressive cancers usually resistant to conventional treatment. Current hypothesis posits that ATC derives from PTC through the progressive acquisition of a discrete number of genomic alterations and implies that the mutational landscape of ATC resembles that of PTC. However, the clinical behaviour of ATC and PTC is radically different. We decided to address the disconnection between the clinical behaviour of ATC and PTC and the proposed model of the progressive development of ATC from PTC. Patients and methods We carried out exome sequencing of DNA from 14 ATC specimens including three cases of concomitant ATC and PTC as well as their corresponding normal DNA from 14 patients. The sequencing results were validated using droplet digital PCR. We carried out immunohistochemistry and immunofluorescence studies of the concomitant ATC and PTC cases. In addition, we integrated our sequencing results with the existing TCGA data. Results Most of the somatic mutations identified in the ATC component differed from the ones in PTC in the cases of concomitant ATC and PTC. The trunks of the phylogenetic trees representing the somatic mutations were short with long branches. In one case of concomitant PTC and ATC specimens, we observed an infiltration of PTC cells within the ATC component. Moreover, we integrated our results with data obtained from TCGA and observed that the most frequent mutations found in ATC presented high cancer cell fraction values and were significantly different from the PTC ones. Conclusion ATC diverge from PTC early in tumour development and both tumour types evolve independently. Our work allows the understanding of the relationship between ATC and PTC facilitating the clinical management of these malignancies.
引用
收藏
页码:1454 / 1460
页数:7
相关论文
共 36 条
  • [1] Integrated Genomic Characterization of Papillary Thyroid Carcinoma
    Agrawal, Nishant
    Akbani, Rehan
    Aksoy, B. Arman
    Ally, Adrian
    Arachchi, Harindra
    Asa, Sylvia L.
    Auman, J. Todd
    Balasundaram, Miruna
    Balu, Saianand
    Baylin, Stephen B.
    Behera, Madhusmita
    Bernard, Brady
    Beroukhim, Rameen
    Bishop, Justin A.
    Black, Aaron D.
    Bodenheimer, Tom
    Boice, Lori
    Bootwalla, Moiz S.
    Bowen, Jay
    Bowlby, Reanne
    Bristow, Christopher A.
    Brookens, Robin
    Brooks, Denise
    Bryant, Robert
    Buda, Elizabeth
    Butterfield, Yaron S. N.
    Carling, Tobias
    Carlsen, Rebecca
    Carter, Scott L.
    Carty, Sally E.
    Chan, Timothy A.
    Chen, Amy Y.
    Cherniack, Andrew D.
    Cheung, Dorothy
    Chin, Lynda
    Cho, Juok
    Chu, Andy
    Chuah, Eric
    Cibulskis, Kristian
    Ciriello, Giovanni
    Clarke, Amanda
    Clayman, Gary L.
    Cope, Leslie
    Copland, John A.
    Covington, Kyle
    Danilova, Ludmila
    Davidsen, Tanja
    Demchok, John A.
    DiCara, Daniel
    Dhalla, Noreen
    [J]. CELL, 2014, 159 (03) : 676 - 690
  • [2] Anaplastic thyroid carcinoma: Behavior, biology, and therapeutic approaches
    Ain, KB
    [J]. THYROID, 1998, 8 (08) : 715 - 726
  • [3] SeqGene: a comprehensive software solution for mining exome- and transcriptome-sequencing data
    Deng, Xutao
    [J]. BMC BIOINFORMATICS, 2011, 12
  • [4] A framework for variation discovery and genotyping using next-generation DNA sequencing data
    DePristo, Mark A.
    Banks, Eric
    Poplin, Ryan
    Garimella, Kiran V.
    Maguire, Jared R.
    Hartl, Christopher
    Philippakis, Anthony A.
    del Angel, Guillermo
    Rivas, Manuel A.
    Hanna, Matt
    McKenna, Aaron
    Fennell, Tim J.
    Kernytsky, Andrew M.
    Sivachenko, Andrey Y.
    Cibulskis, Kristian
    Gabriel, Stacey B.
    Altshuler, David
    Daly, Mark J.
    [J]. NATURE GENETICS, 2011, 43 (05) : 491 - +
  • [5] Circulating mutant DNA to assess tumor dynamics
    Diehl, Frank
    Schmidt, Kerstin
    Choti, Michael A.
    Romans, Katharine
    Goodman, Steven
    Li, Meng
    Thornton, Katherine
    Agrawal, Nishant
    Sokoll, Lori
    Szabo, Steve A.
    Kinzler, Kenneth W.
    Vogelstein, Bert
    Diaz, Luis A., Jr.
    [J]. NATURE MEDICINE, 2008, 14 (09) : 985 - 990
  • [6] Noninvasive Identification and Monitoring of Cancer Mutations by Targeted Deep Sequencing of Plasma DNA
    Forshew, Tim
    Murtaza, Muhammed
    Parkinson, Christine
    Gale, Davina
    Tsui, Dana W. Y.
    Kaper, Fiona
    Dawson, Sarah-Jane
    Piskorz, Anna M.
    Jimenez-Linan, Mercedes
    Bentley, David
    Hadfield, James
    May, Andrew P.
    Caldas, Carlos
    Brenton, James D.
    Rosenfeld, Nitzan
    [J]. SCIENCE TRANSLATIONAL MEDICINE, 2012, 4 (136)
  • [7] Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing
    Gerlinger, Marco
    Rowan, Andrew J.
    Horswell, Stuart
    Larkin, James
    Endesfelder, David
    Gronroos, Eva
    Martinez, Pierre
    Matthews, Nicholas
    Stewart, Aengus
    Tarpey, Patrick
    Varela, Ignacio
    Phillimore, Benjamin
    Begum, Sharmin
    McDonald, Neil Q.
    Butler, Adam
    Jones, David
    Raine, Keiran
    Latimer, Calli
    Santos, Claudio R.
    Nohadani, Mahrokh
    Eklund, Aron C.
    Spencer-Dene, Bradley
    Clark, Graham
    Pickering, Lisa
    Stamp, Gordon
    Gore, Martin
    Szallasi, Zoltan
    Downward, Julian
    Futreal, P. Andrew
    Swanton, Charles
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (10) : 883 - 892
  • [8] The Variable Presentations of Anaplastic Spindle Cell Squamous Carcinoma Associated with Tall Cell Variant of Papillary Thyroid Carcinoma
    Gopal, Pallavi P.
    Montone, Kathleen T.
    Baloch, Zubair
    Tuluc, Madalina
    LiVolsi, Virginia
    [J]. THYROID, 2011, 21 (05) : 493 - 499
  • [9] Genetic alterations and their relationship in the phosphatidylinositol 3-kinase/Akt pathway in thyroid cancer
    Hou, Peng
    Liu, Dingxie
    Shan, Yuan
    Hu, Shuiying
    Studeman, Kimberley
    Condouris, Stephen
    Wang, Yangang
    Trink, Ariel
    El-Naggar, Adel K.
    Tallini, Giovanni
    Vasko, Vasily
    Xing, Mingzhao
    [J]. CLINICAL CANCER RESEARCH, 2007, 13 (04) : 1161 - 1170
  • [10] Genomic Alterations of Anaplastic Thyroid Carcinoma Detected by Targeted Massive Parallel Sequencing in a BRAFV600E Mutation-Prevalent Area
    Jeon, Min Ji
    Chun, Sung-Min
    Kim, Deokhoon
    Kwon, Hyemi
    Jang, Eun Kyung
    Kim, Tae Yong
    Kim, Won Bae
    Shong, Young Kee
    Jang, Se Jin
    Song, Dong Eun
    Kim, Won Gu
    [J]. THYROID, 2016, 26 (05) : 683 - 690